FFA
ALNY icon

Farther Finance Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Farther Finance Advisors’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$345K Buy
1,146
+236
+26% +$71.2K ﹤0.01% 1844
2026
Q1 		$299K Sell
910
-325
-26% -$111K ﹤0.01% 1733
2025
Q4 		$491K Buy
1,235
+507
+70% +$224K 0.01% 1321
2025
Q3 		$332K Buy
728
+349
+92% +$142K 0.01% 1327
2025
Q2 		$123K Buy
379
+138
+57% +$38.2K ﹤0.01% 1655
2025
Q1 		$61.6K Hold
241
– – ﹤0.01% 1795
2024
Q4 		$56.8K Buy
241
+30
+14% +$7.89K ﹤0.01% 1595
2024
Q3 		$58.1K Buy
211
+103
+95% +$26.8K ﹤0.01% 1570
2024
Q2 		$26.3K Buy
108
+39
+57% +$6.16K ﹤0.01% 1680
2024
Q1 		$10.6K Sell
69
-25
-27% -$4.17K ﹤0.01% 1743
2023
Q4 		$18K Buy
94
+69
+276% +$11.8K ﹤0.01% 1365
2023
Q3 		$4.43K Buy
25
+4
+19% +$763 ﹤0.01% 1552
2023
Q2 		$3.99K Buy
21
+5
+31% +$991 ﹤0.01% 1508
2023
Q1 		$3.21K Hold
16
– – ﹤0.01% 1466
2022
Q4 		$3.8K Buy
+16
New +$3.41K ﹤0.01% 1260

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Farther Finance Advisors's ALNY Position: Q2 2026 in Review

Farther Finance Advisors increased its Alnylam Pharmaceuticals (ALNY) stake by 26% in Q2 2026, buying an estimated $71.2K and bringing the position to 1,146 shares worth $345K. The position accounts for ﹤0.01% of the portfolio, ranked #1844.

Farther Finance Advisors first reported a position in ALNY in Q4 2022 and has held it in 15 quarters since. The position peaked at $491K in Q4 2025. 785 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Farther Finance Advisors held 1,146 shares of Alnylam Pharmaceuticals worth $345K as of Q2 2026.
  • Farther Finance Advisors bought 236 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $71.2K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #1844 holding.
  • Farther Finance Advisors first reported a position in Alnylam Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • Farther Finance Advisors's Alnylam Pharmaceuticals position peaked at $491K in Q4 2025.
  • 785 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.